Please assess the completion status of the following clinical trial:

Trial Title: Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes~* Inadequate blood sugar control~Exclusion Criteria:~* Previous treatment for diabetes~* Current treatment with other medications to lower blood sugar~* Major heart, liver or kidney problems~* Women who are pregnant or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 77 Years
- Healthy Volunteers: f

Study Arms:
- Saxagliptin 2.5 mg QAM (A) (Type: EXPERIMENTAL): PLUS open-label metformin (as needed as rescue medication)
- Saxagliptin 2.5 mg titrated to 5 mg QAM (B) (Type: EXPERIMENTAL): PLUS open-label metformin (as needed as rescue medication)
- Saxagliptin 5 mg QAM (C) (Type: EXPERIMENTAL): PLUS open-label metformin (as needed as rescue medication)
- Saxagliptin 5 mg QPM (D) (Type: EXPERIMENTAL): PLUS open-label metformin (as needed as rescue medication)
- Placebo (E) (Type: PLACEBO_COMPARATOR): PLUS open-label metformin (as needed as rescue medication)

Based on this trial design, predict the completion outcome and termination type (if applicable).